First published online January 23, 2009
doi: 10.1242/10.1242/dev.027748
Development 136, 585-594 (2009)
Published by The Company of Biologists 2009
Sall genes regulate region-specific morphogenesis in the mouse limb by modulating Hox activities
Yasuhiko Kawakami1,2,3,4,
Yukako Uchiyama5,
Concepcion Rodriguez Esteban1,
Toshiaki Inenaga5,
Naoko Koyano-Nakagawa2,4,6,
Hiroko Kawakami1,2,3,
Merce Marti7,
Marie Kmita8,
Paula Monaghan-Nichols9,
Ryuichi Nishinakamura5 and
Juan Carlos Izpisua Belmonte1,7,*
1 Gene Expression Laboratory, The Salk Institute for Biological Studies, 10010
N. Torrey Pines Road, La Jolla, CA 92037, USA.
2 Stem Cell Institute, University of Minnesota, 2001 6th SE, Minneapolis, MN.
55455, USA.
3 Department of Genetics, Cell Biology and Development, 6-160 Jackson Hall, 321
Church St. SE, Minneapolis, MN 55455, USA.
4 Developmental Biology Center, University of Minnesota, 321 Church St. SE,
Minneapolis, MN 55455, USA.
5 Division of Integrative Cell Biology, Institute of Molecular Embryology and
Genetics, Global COE `Cell Fate Regulation Research and Education Unit',
Kumamoto University, Kumamoto, Japan 860-0811.
6 Department of Neuroscience, University of Minnesota, 321 Church St. SE,
Minneapolis, MN 55455, USA.
7 Center of Regenerative Medicine in Barcelona, Doctor Aiguader, 88, 08003
Barcelona, Spain.
8 Laboratory of Genetics and Development, Institut de Recherches Cliniques de
Montréal (IRCM), Université de Montréal, 110 avenue des
Pins Ouest, H2W 1R7, Montréal, Quebec, Canada.
9 Department of Neurobiology, University of Pittsburgh, Pittsburgh, PA 15261,
USA.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 1. Combined activity of Sall1 and Sall3 contributes to
the development of the autopod. Alcian Blue-stained E15.5 forelimbs of
Sall1;Sall3 mutants are shown. Genotypes of Sall1;Sall3 are
indicated on the top: (A) +/+;+/+, (B) +/-;+/-, (C)
+/+;-/-, (D) +/-;-/-, (E) -/-;+/+, (F) -/-;+/- and
(G) -/-;-/-. Middle panels show lateral views of entire forelimb
skeletons, and the bottom panels show dorsal views of the autopod. In A, the
stylopod, zeugopod and autopod are indicated as S, Z and A, and digits are
indicated with 1-5. Metacarpal fusions in the
Sall1-/-;Sall3+/+ (E),
Sall1-/-;Sall3+/- (F) and
Sall1-/-;Sall3-/-
(G) mutants are indicated by arrows. Two small carpal elements left in the
Sall1-/-;Sall3-/-
(G) mutant are indicated by asterisks. Skeletal phenotypes become more severe
from the left (Sall1+/+;Sall3+/+; A)
to the right
(Sall1-/-;Sall3-/-;
G).
|
|

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 2. Expression of Sall1 and Sall3 is regulated by
Shh-Gli3. Dorsal views of E10.5 forelimbs stained with Sall1
(A-C) and Sall3 (D-F) with the anterior towards the
top. Wild-type (WT; A,D), Shh-/- (B,E)
and Gli3-/- (C,F) limbs are shown.
Normal expression of Sall1 and Sall3 is restricted to the
distal-posterior mesenchyme (A,D; black arrows). Both Sall1 and
Sall3 are downregulated in
Shh-/- limbs (B,E; red arrows), and
are ectopically expressed in the anterior mesenchyme in the
Gli3-/- limbs (C,F; blue arrows).
|
|

View larger version (87K):
[in this window]
[in a new window]
|
Fig. 3. Reduced Shh signaling in
Sall1-/-;Sall3-/-
mutant limbs. Dorsal views of E10.5 (A,B) and E11.5 (C-H) limb buds
stained with Grem1 (A-D), Sox9 (E,F) and Fgf8
(G,H), with the anterior towards the top. Wild-type (WT; A,C,E,G) and
Sall1-/-;Sall3-/-
(B,D,F,H) limbs are shown. (A-D) Grem1 expression is
downregulated in the mutant limb (B,D; arrows), compared with control limbs
(A,C). (E,F) Morphological alteration was visible at E11.5 by
Sox9 in situ hybridization. The control limb has primordia for
digit1-digit5 (E). The mutant limb lacks digit1 primordia, exhibits fused
digit2 and digit3 primordia, and has delayed separation of digit4 and digit5
primordia (F). (G,H) The Fgf8 expression domain is shorter
along the anterior-posterior axis in the AER in the mutant (H), compared with
the control limb (G). The anterior and posterior margins of Fgf8
expression domain are indicated by arrows.
|
|

View larger version (63K):
[in this window]
[in a new window]
|
Fig. 4. Expression of Epha3 and Epha4 is upregulated in the
Hoxa13 and Hoxd13 mutants. Dorsal views of E11.5
forelimbs stained with Epha3 (A-C) and Epha4
(D-F) with the anterior towards the top. Wild-type (WT; A,D),
Hoxa13-/- (B,E) and
Hoxd13-/- (C,F) limbs are shown.
Normal Epha3 expression in the anterior edge (arrow) and prospective
wrist region (arrowhead) (A) is upregulated and expanded posteriorly in the
Hoxa13-/- (B, arrow) and
Hoxd13-/- (C, arrow) limbs. Normal
Epha4 expression in the distal-anterior mesenchyme (D, arrow) is
upregulated and expanded distal-posteriorly in the
Hoxa13-/- (E, arrow) and
Hoxd13-/- (F, arrow) limbs.
|
|

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 5. Expression of Epha3 and Epha4 is downregulated in
Sall1;Sall3 mutant limbs. Dorsal views of E11.5 forelimbs stained
with Epha3 (A-C) and Epha4 (D-F) with the anterior towards
the top. Wild-type (A,D),
Sall1-/-;Sall3+/- (B,E) and
Sall1-/-;Sall3-/-
(C,F) limbs are shown. (A) Normal expression of Epha3 is
detected in the anterior edge (arrow) and prospective wrist region
(arrowhead). (B) Epha3 expression is downregulated in the
Sall1-/-;Sall3+/- limb.
(C) The anterior edge expression is more severely downregulated and the
prospective wrist region expression is undetectable in the
Sall1-/-;Sall3-/-
limb. (D) Normal Epha4 expression in detected the distal
anterior mesenchyme (arrow). (E,F) Epha4 expression is
downregulated in the
Sall1-/-;Sall3+/- limb (E),
and is more severely downregulated in the
Sall1-/-;Sall3-/-
limb (F).
|
|

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 6. Hox represses the expression of Sall1 and
Sall3. Dorsal views of E11.5 hindlimbs stained with
Sall1 (A-D) and Sall3 (E-H) with anterior towards the top.
Wild-type (A,E), Hoxa13-/- (B,F),
Hoxd13-/- (C,G) and
Hoxa13-/-;Hoxd13-/-
(D,H) limbs are shown. (A) Normal Sall1 expression starts to
regress from the most distal mesenchyme (arrow). (B) In the
Hoxa13-/- limb, the Sall1
expression domain became larger and the signal stronger. (C) In the
Hoxd13-/- limb, the Sall1
signal is detected in the distal region (arrow) and is stronger than that in
the wild type. (D) In the
Hoxa13-/-;Hoxd13-/-
limb, a large domain in the distal mesenchyme expresses significantly high
levels of Sall1 (arrow). (E) Normal Sall3 expression
also starts to regress from the most distal mesenchyme (arrow). (F) In
the Hoxa13-/- limb, higher level of
Sall3 expression is detected in the anterior mesenchyme (arrow).
(G) In the Hoxd13-/- limb,
higher level of Sall3 expression is detected in the distal-middle
region (arrow). (H) In the
Hoxa13-/-;Hoxd13-/-
limb, strong expression of Sall3 is detected in the wide region of
the distal mesenchyme.
|
|

View larger version (74K):
[in this window]
[in a new window]
|
Fig. 7. Sall1 modulates Hox activity post-transcriptionally. (A) EMSA
assay with the HA-Sall1 protein. Sall1 recognizes the Epha4 upstream
element (arrow). The specificity was confirmed by supershift induced by
anti-HA antibody (asterisk). The Sall1-probe complex became weaker by
introducing mutations in the probe (M1, M2), and is abolished by introducing
multiple mutations (M3). (B,C) EMSA assay with Flag-Hoxa13 protein (B)
and Flag-Hoxd13 protein (C). Both Hoxa13 and Hoxd13 recognize the
Epha4 upstream element (arrows). The specificity was confirmed by
supershift induced by anti-Flag antibody (asterisks). The Hox13-probe complex
was weaker with the M1 mutant probe, but was not severely affected with the M2
mutant probe. The binding was abolished with the M3 mutant probe containing
multiple mutations. M1, mutant1; M2, mutant2; M3, mutant3 (see Materials and
methods). (D) Sall1 and Hox13 compete for an Epha4 upstream
element. Specific bands formed between 32P-labeled wild-type probe
and Sall1 (arrow), and between 32P-labeled wild-type probe and
Hox13 (broken arrow) were detected. By co-incubating with Sall1, the
Hoxa13-DNA complex and the Hoxd13-DNA complex became weaker. (E)
Luciferase-reporter assay showing Hox-activity modulation by Sall1. The
reporter construct was co-transfected with 100 ng of Hoxa13, Hoxd13 and/or
Sall1 expression constructs, together with 20 ng pRL-TK. Data are shown as
mean±s.d. Significant differences between mock transfected (moc), and
Hoxd13, Hoxd13 and Hoxd13+Sall1 are detected (P<0.001).
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati
Twitter What's this?
© The Company of Biologists Ltd 2009